Analystreport

InVivo Therapeutics Hldg (NASDAQ: NVIV) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

InVivo Therapeutics Holdings Corp.  (NVIV) 
Last invivo therapeutics holdings corp. earnings: 5/7 04:30 pm Check Earnings Report